Tag: CBD
-
The Curious Case of Maple Leaf Green World (MGW.C)
Long time readers will remember the weird ass name of Maple Leaf Green World (MGW.C) from several years back in the cannabis space, when a group arrived from China determined to make their riches in the North American weed fields, only to end up in a small, dank, broken down greenhouse in Nevada, under a…
-
Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies
Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid and exact dose products. “This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide…
-
To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)
In this episode, we take a look at a cannabis, hemp and psychedelics extraction company based in British Columbia that goes by the name Pure Extracts Technologies Corp. (PULL.C). The company offers various derivative cannabis products such as Pure Mushrooms, which are daily supplements aimed at boosting the immune system and overall health and wellness;…
-
First Glance with Jody Vance: Pure Extracts (PULL.C)
In episode 69, Jody chats with Pure Extracts (PULL.C) CEO Ben Nikolaevsky to get an insight into the companies latest updates and plans. Pure Extracts operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts.
-
Revive Therapeutics (RVV.C) incredible patent-portfolio explained
Revive Therapeutics (RVV.C) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. RVV holds 13 patents (issued and provisional) for covid-treatment, gout, drug delivery systems, cannabidiol and psilocybin. “We are proud of the IP portfolio that we’ve generated,” stated Michael Frank, CEO of Revive…
-
Revive Therapeutics (RVV.C) latest spate of Bucillamine research could slow COVID-19 infection rates
Revive Therapeutics (RVV.C) signed a research agreement with the University of California, San Francisco (UCSF) to explore Bucillamine as a potential treatment for severe cases of COVID-19 today, according to a press release. The research will be done by Dr. John Fahy with the intention of testing the efficacy of Bucillamine in pre-clinical models of…
-
Xphyto (XPHY.C) bulks up executive team as Covid-19 ravages Europe
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
-
Pure Extracts (PULL.C) to enter U.S. market through JV in Michigan
If the LOI becomes a binding contract, Pure Extracts will contribute “a mix of equipment and cash to the venture”, which will allow the partners to rapidly scale-up to meet the rising demand for recreation cannabis concentrates and edibles throughout Michigan.
-
Discover Wellness (WLNS.C) enters the $3.5 billion global CBD market with a lean mean business model
“The contribution of this first 550,000 kg of high-CBD biomass from SG and the completion of the Strategic Alliance agreement is a significant first step in leveraging the combined resources under the Discover Wellness umbrella,” stated Peter Cheung, Interim CEO of WLNS,